We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 45.04% ...

Sana Biotechnology Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -44.77%. The profit margin, also known as the revenue ratio or gross profit ratio ...

Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered ...

Sana stock is likely to correct downwards as the market prepares to wait years for more study data that could be used to support a formal approval submission," Ingham added.

Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced significant moves in its stock performance, attracting investor attention.

If you are looking for an AI stock that is more promising than SANA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 10 Hottest Mid ...

As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, ...

Price Action: At the last check on Wednesday, SANA stock was up 263.60% at $6.01 during the premarket session.

Sana’s HIP technology aims to eliminate the ... In three months, CytomX Therapeutics’ stock has lost 14.5%. CTMX’s earnings beat estimates in two of the trailing four quarters and missed ...